ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
23 hedge funds and large institutions have $4.03M invested in Oncternal Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$269K | |
| 2 | +$93.9K | |
| 3 | +$38.4K | |
| 4 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$26.5K |
| 5 |
Renaissance Technologies
New York
|
+$23.7K |
Top Sellers
| 1 | -$18.7K | |
| 2 | -$10.7K | |
| 3 | -$8K | |
| 4 |
Morgan Stanley
New York
|
-$3.58K |
| 5 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$3.36K |